Overview

A Study to Investigate The Duration of Treatment Effect and Re-treatment With Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain

Status:
Not yet recruiting

Trial end date:
2024-10-24

Target enrollment:

Participant gender:

Summary

The purpose of this study is to measure the duration of treatment effect and response to re-treatment with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with placebo in adult participants with knee osteoarthritis (OA) pain. Study details include: - The study duration will be up to 28, 56, 68, or 80 weeks depending on treatment received in the parent study and response to treatment. - If participating in the Treatment Part of the study: - The treatment duration will be up to 6 weeks - The visit frequency will be twice weekly during the Treatment Period.

Phase:

Phase 3

Details

Lead Sponsor:

Paradigm Biopharmaceuticals USA (INC)

Treatments:

Pentosan Sulfuric Polyester